Belleville, New Jersey Clinical Trials
A listing of Belleville, New Jersey clinical trials actively recruiting patient volunteers.
Found 124 clinical trials
- 0 views
- 19 Feb, 2024
- +3 other locations
iConnect R12.3 UAT Dry Run Script 03-1
iConnect R12.3 UAT Dry Run Script 05-1<br>
- 0 views
- 08 May, 2025
- 1 location
iConnect R12.3.1 UAT Dry Run for Site Question
iConnect R12.3.1 UAT Dry Run for Site Question
- 0 views
- 17 Apr, 2024
- +1 other locations
![6.14 Program Trial 1 - [18 to 35 yo]](/media/imagery/13374.svg)
6.14 Program Trial 1 - [18 to 35 yo]
6.14 Program Trial 1 - [18 to 35 yo]
- 0 views
- 04 Aug, 2024
- 1 location
![6.14 Program Trial 2 - [36 to 65 yo]](/media/imagery/13375.svg)
6.14 Program Trial 2 - [36 to 65 yo]
6.14 Program Trial 1 - [36 to 65 yo]
- 0 views
- 23 Apr, 2024
- 1 location
![6.14 Program Trial 3 - [over 65 yo]](/media/imagery/13376.svg)
6.14 Program Trial 3 - [over 65 yo]
6.14 Program Trial 3 - [over 65 yo]
- 0 views
- 24 Apr, 2024
- 1 location
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)
- 0 views
- 19 Feb, 2024
- +10 other locations
Multi-center Open-label Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Primary Objectives: To evaluate the safety and tolerability of isatuximab administered subcutaneously (SC) versus intravenously (IV) To evaluate the pharmacokinetics (PK) of SC and IV isatuximab Secondary Objectives: To estimate absolute bioavailability of SC and IV isatuximab To measure receptor occupancy (RO) after isatuximab SC versus IV administration To assess …
- 0 views
- 24 Nov, 2025
- +13 other locations